An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
Recruiting
Observational Study
Congenital Heart Disease
Coarctation of Aorta
Aortic Stenosis
Pulmonary Atresia
Pulmonary Stenosis
Transposition of the Great Arteries
Truncus Arteriosus
Single Ventricle
Tetralogy of Fallot (TOF)
Interrupted Aortic Arch
Hypoplastic Left Heart Syndrome (HLHS)
Total Anomalous Pulmonary Venous Connection
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 Day – 28 Days
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Beijing Anzhen Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this two-way cohort study was to explore whether an integrated prenatal and postnatal treatment model for neonates with critical congenital heart disease (CCHD) could be effective in avoiding preoperative morbidities, creating an ideal timing for surgery, thereby reducing postoperative in-hospital mortality, and improving surgical prognosis compared with the traditional model of car…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Full-term infants (gestational age 37-40 weeks): age less than 28 days;
2. Preterm infants (gestational age greater than 32 weeks but less than 37 weeks): corrected gestational age as neonatal period, age less than 28 days;
3. Birth weight \> 1.5 kg;
4. Fetal diagnosis of con…
Contacts
Qiang Wang, MD
86+ 13691061902
CONTACT